LISATA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
LISATA THERAPEUTICS, INC. (LSTA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value of $253.90 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue · last filed 2026-08-06
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $253.90K.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $1.84M.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $24.60K.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $110.30K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value as first filed |
|---|---|---|
| 2026-06-30 | $253.90K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.84M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $24.60K 10-K · filed 2026-03-12 | |
| 2025-09-30 | $110.30K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $142.70K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $79.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $157.00K 10-K · filed 2025-02-27 | |
| 2024-09-30 | $199.20K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $346.70K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $231.50K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $164.10K 10-K · filed 2024-02-29 | |
| 2023-09-30 | $78.70K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $373.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $358.20K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $187.60 10-K · filed 2023-03-30 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $0.00 10-K · filed 2022-03-22 | |
| 2020-12-31 | $0.00 10-K · filed 2021-02-25 | |
| 2019-12-31 | $0.00 10-K · filed 2020-03-05 | |
| 2018-12-31 | $3.30K 10-K · filed 2019-03-14 | |
| 2017-12-31 | $100.00 10-K · filed 2019-03-14 | |
| 2017-03-31 | $133.60K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-22 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-11-07 | $9.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $52.40K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $100.00 10-K · filed 2017-03-17 | $0.00 10-K · filed 2016-03-15 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $28.60K 10-K · filed 2016-03-15 | $16.60K 10-K · filed 2015-03-02 |
| 2014-09-30 | $403.90K 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $1.12M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $1.60M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $1.66M 10-K · filed 2015-03-02 | $1.28M 10-K · filed 2014-03-13 |
| 2012-12-31 | $1.66M 10-K · filed 2014-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |